Browse result page of THPdb

The total number entries retrieved from this search are 26

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1005	ThPPIDTh1002	NameCetuximab	Peptide SequenceHeavy chain:QVQLKQSG Full view	Length243	Functional ClassificationIIIc	DiseaseCancer	BrandErbitux	CompanyImClone Systems Inc	Physical AppearanceSterile, clear, colorless liquid of pH 7.0-7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulates	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetEpidermal growth factor receptor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1074	ThPPIDTh1013	NameEpoetin alfa	Peptide SequenceAPPRLICDSRVLERYLLEAK Full view	Length166	Functional ClassificationIb	DiseaseHematological	BrandEpogen	CompanyAmgen Inc.	Physical AppearanceSterile, colorless liquid	Route of AdministartionSubcutaneous Injection	CategoryAnti-anemic Agents, Hematinics	TargetErythropoietin receptor
ID1078	ThPPIDTh1013	NameEpoetin alfa	Peptide SequenceAPPRLICDSRVLERYLLEAK Full view	Length166	Functional ClassificationIb	DiseaseHematological	BrandProcrit	CompanyOrtho Biotech	Physical AppearanceSterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solution	Route of AdministartionIntravenous(IV) or Subcutaneous (SC) administration.	CategoryAnti-anemic Agents, Hematinics	TargetErythropoietin receptor
ID1194	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandFlebogamma	CompanyInstituto Grifols SA	Physical AppearanceSterile, clear or slightly opalescent and colorless to pale yellow, liquid	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1341	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandAvonex	CompanyBiogen Inc	Physical AppearanceLyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector.	Route of AdministartionIntramuscular Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1379	ThPPIDTh1058	NameInterferon alfacon-1	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological/Infectious	BrandINFERGEN	CompanyKadmon Pharmaceuticals, LLC.	Physical AppearanceSterile, clear, colorless, preservative-free liquid	Route of AdministartionSubcutaneous Injection	CategoryAntiviral Agents and Immunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1465	ThPPIDTh1089	NamePalivizumab	Peptide SequenceVH region: QVTLRESG< Full view	Length120	Functional ClassificationIIIa	DiseaseInfectious	BrandSynagis	CompanyMedImmune	Physical AppearanceSterile, preservative-free liquid solution	Route of AdministartionIntramuscular injection	CategoryAntiviral Agents	TargetN.A.
ID1474	ThPPIDTh1094	NamePanitumumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseCancer	BrandVectibix	CompanyAmgen Inc	Physical AppearanceSterile, colorless, pH 5.6 to 6.0 liquid for intravenous (IV) infusion, which may contain a small amount of visible translucent-to-white, amorphous, proteinaceous, panitumumab particulates	Route of AdministartionN.A.	CategoryN.A.	TargetEpidermal growth factor receptor
ID1550	ThPPIDTh1119	NameTocilizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandACTEMRA	CompanyGenentech	Physical AppearanceSterile, preservative-free solution, colorless to pale yellow liquid, with a pH of about 6.5	Route of AdministartionIntravenous infusion, Subcutaneous injection	CategoryN.A.	TargetInterleukin-6 receptor subunit alpha
ID1560	ThPPIDTh1121	NamePertuzumab	Peptide Sequencelight chain DIQMTQSP Full view	Length664	Functional ClassificationIIIc	DiseaseCancer	BrandPerjeta	CompanyGenentech	Physical AppearanceSterile, clear to slightly opalescent, colorless to pale brown liquid	Route of AdministartionIntravenous infusion	CategoryMonoclonal antibodies	TargetReceptor tyrosine-protein kinase erbB-2
ID1624	ThPPIDTh1137	NameTeduglutide	Peptide SequenceHGDGSFSDEMNTILDNLAAR Full view	Length33	Functional ClassificationIa	DiseaseMalabsorption disorder	BrandGattex	CompanyNPS Pharmaceuticals, Inc	Physical AppearanceClear, colorless to light-straw–colored liquid.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetGlucagon-like peptide 2 receptor
ID1627	ThPPIDTh1138	NameRaxibacumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological/Infectious	BrandRAXIBACUMAB	CompanyGSK	Physical AppearanceSterile, liquid formulation in single-dose vials	Route of AdministartionN.A.	CategoryAnti-Infective Agents and Monoclonal antibodies	TargetProtective antigen
ID1636	ThPPIDTh1142	NameObinutuzumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseCancer	BrandGazyva	CompanyGenentech	Physical AppearanceSterile, clear, colorless to slightly brown, preservative free liquid concentrate	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetB-lymphocyte antigen CD20
ID1768	ThPPIDTh1186	NameHuman rabies virus immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIa	DiseaseInfectious Disease	BrandHyperab Rabies Immune Globulin Human	CompanyCutter Med & Biol, Division Of Miles Canada Ltd.	Physical AppearanceLiquid	Route of AdministartionIntramuscular	CategoryNA	TargetNA
ID1770	ThPPIDTh1186	NameHuman rabies virus immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIa	DiseaseInfectious Disease	BrandImogam Rabies Inj 150unit/ml	CompanyPasteur mÉrieux Serums Et Vaccins, s.a.	Physical AppearanceClear, pale yellow to light brown liquid	Route of AdministartionIntramuscular	CategoryNA	TargetNA
ID1772	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandHyp Rho D Inj 16.5%	CompanyCutter Med & Biol, Division Of Miles Canada Ltd.	Physical Appearanceliquid	Route of AdministartionIntramuscular	CategoryNA	TargetNA
ID1779	ThPPIDTh1187	NameHuman Rho(D) immune globulin	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandWinrho Sdf (liquid Formulation)	CompanyAptevo Biotherapeutics Llc	Physical Appearanceliquid	Route of AdministartionIntramuscular; Intravenous	CategoryNA	TargetNA
ID1793	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandGamastan	CompanyCutter Med & Biol, Division Of Miles Canada Ltd.	Physical Appearanceliquid	Route of AdministartionIntramuscular	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1795	ThPPIDTh1190	NameImmune Globulin Human	Peptide SequenceIGG1: PSALTQPPSASGSL Full view	Length1338	Functional ClassificationIIIb	DiseaseImmunological Disorders	BrandHyqvia	CompanyBaxalta Us Inc.	Physical AppearanceLiquid	Route of AdministartionIntravenous infusion	CategoryImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents	TargetHigh affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
ID1813	ThPPIDTh1204	NameOfatumumab	Peptide SequenceOfatumumab Heavy Cha Full view	Length483	Functional ClassificationIIIc	DiseaseCancer	BrandArzerra	CompanyGlaxo Smith Kline Llc	Physical AppearanceLiquid	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	Target
ID1814	ThPPIDTh1205	NameObiltoxaximab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIa	DiseaseInfectious Disease	BrandAnthim	CompanyElusys Therapeutics, Inc.	Physical AppearanceLiquid	Route of AdministartionIntravenous infusion	CategoryNA	TargetNA
ID1815	ThPPIDTh1206	NameNivolumab	Peptide SequenceHeavy Chain Sequence Full view	Length710	Functional ClassificationIIIc	DiseaseCancer	BrandOpdivo	CompanyE.R. Squibb & Sons, L.L.C.	Physical AppearanceLiquid	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	TargetProgrammed cell death protein 1
ID1826	ThPPIDTh1216	NameAnthrax immune globulin human	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandANTHRASIL	CompanyCangene Corporation	Physical AppearanceLiquid	Route of AdministartionIntravenous	CategoryPlasma derivative	TargetProtective antigen
ID1831	ThPPIDTh1221	NameC1 Esterase Inhibitor (Recombinant)	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseCardiac Disorders	BrandRuconest	CompanyTjoapack Netherlands Bv	Physical AppearancePowder and liquid for solution	Route of AdministartionIntravenous	CategoryBlood and Blood Forming Organs	TargetComplement C1r subcomponent, Complement C1s subcomponent, Plasma kallikrein, Coagulation factor XII, Prothrombin, Coagulation factor XI, Tissue-type plasminogen activator
ID1850	ThPPIDTh1237	NameSomatropin recombinant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length191	Functional ClassificationIb	DiseaseHormonal Disorders	BrandNutropinAQ	CompanyGenentech Inc.	Physical AppearanceSterile liquid	Route of AdministartionSubcutaneous	CategoryHormones, Hormone Substitutes, and Hormone Antagonists	TargetGrowth hormone receptor, Prolactin receptor